# API-CAT (NCT03692065)

> API-CAT STUDY for APIxaban Cancer Associated Thrombosis

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03692065
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Assistance Publique - Hôpitaux de Paris
- Conditions: Cancer-associated Thrombosis
- Interventions: Apixaban 5 MG
- Enrollment: 1766
- Primary outcome: The incidence of an an adjudicated composite endpoint

## Commentary we found

- Podcasts: 9
- X threads: 7
- YouTube: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=api-cat-nct03692065

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03692065", "email": "<work email>"}; the inbox owner confirms by the emailed link.